6-(cyclohexen-1-yl)-2-cyclopropyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;6-(cyclohexen-1-yl)-2-methyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;N-(cyclopentylmethyl)-8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazine-2-carboxamide;(4-methylpiperazin-1-yl)-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone;morpholin-4-yl-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone

C109H115F15N24O4 — CID 164948881

IUPAC6-(cyclohexen-1-yl)-2-cyclopropyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;6-(cyclohexen-1-yl)-2-methyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;N-(cyclopentylmethyl)-8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazine-2-carboxamide;(4-methylpiperazin-1-yl)-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone;morpholin-4-yl-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone
SMILESC[C@@H](Nc1nc(C2CC2)nn2cc(C3=CCCCC3)cc12)c1cccc(C(F)(F)F)c1.C[C@@H](Nc1nccn2cc(C(=O)N3CCN(C)CC3)nc12)c1cccc(C(F)(F)F)c1.C[C@@H](Nc1nccn2cc(C(=O)N3CCOCC3)nc12)c1cccc(C(F)(F)F)c1.C[C@@H](Nc1nccn2cc(C(=O)NCC3CCCC3)nc12)c1cccc(C(F)(F)F)c1.Cc1nc(N[C@H](C)c2cccc(C(F)(F)F)c2)c2cc(C3=CCCCC3)cn2n1
InChIInChI=1S/C24H25F3N4.C22H24F3N5O.C22H23F3N4.C21H23F3N6O.C20H20F3N5O2/c1-15(18-8-5-9-20(12-18)24(25,26)27)28-23-21-13-19(16-6-3-2-4-7-16)14-31(21)30-22(29-23)17-10-11-17;1-14(16-7-4-8-17(11-16)22(23,24)25)28-19-20-29-18(13-30(20)10-9-26-19)21(31)27-12-15-5-2-3-6-15;1-14(17-9-6-10-19(11-17)22(23,24)25)26-21-20-12-18(16-7-4-3-5-8-16)13-29(20)28-15(2)27-21;1-14(15-4-3-5-16(12-15)21(22,23)24)26-18-19-27-17(13-30(19)7-6-25-18)20(31)29-10-8-28(2)9-11-29;1-13(14-3-2-4-15(11-14)20(21,22)23)25-17-18-26-16(12-28(18)6-5-24-17)19(29)27-7-9-30-10-8-27/h5-6,8-9,12-15,17H,2-4,7,10-11H2,1H3,(H,28,29,30);4,7-11,13-15H,2-3,5-6,12H2,1H3,(H,26,28)(H,27,31);6-7,9-14H,3-5,8H2,1-2H3,(H,26,27,28);3-7,12-14H,8-11H2,1-2H3,(H,25,26);2-6,11-13H,7-10H2,1H3,(H,24,25)/t15-;3*14-;13-/m11111/s1
InChIKeyAGGBCGHHCFWNTG-BKZBUSBYSA-N
MW2110.25 g/mol
LogP24.49
Rot. Bonds23

About 6-(cyclohexen-1-yl)-2-cyclopropyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;6-(cyclohexen-1-yl)-2-methyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;N-(cyclopentylmethyl)-8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazine-2-carboxamide;(4-methylpiperazin-1-yl)-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone;morpholin-4-yl-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone

6-(cyclohexen-1-yl)-2-cyclopropyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;6-(cyclohexen-1-yl)-2-methyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;N-(cyclopentylmethyl)-8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazine-2-carboxamide;(4-methylpiperazin-1-yl)-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone;morpholin-4-yl-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone (PubChem CID 164948881) has the molecular formula C109H115F15N24O4 and a molecular weight of 2110.25 g/mol. Its IUPAC name is 6-(cyclohexen-1-yl)-2-cyclopropyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;6-(cyclohexen-1-yl)-2-methyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;N-(cyclopentylmethyl)-8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazine-2-carboxamide;(4-methylpiperazin-1-yl)-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone;morpholin-4-yl-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone.

Molecular Properties

Compound Name6-(cyclohexen-1-yl)-2-cyclopropyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;6-(cyclohexen-1-yl)-2-methyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;N-(cyclopentylmethyl)-8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazine-2-carboxamide;(4-methylpiperazin-1-yl)-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone;morpholin-4-yl-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone
PubChem CID164948881
Molecular FormulaC109H115F15N24O4
Molecular Weight2110.25 g/mol
Exact Mass2108.93
IUPAC Name6-(cyclohexen-1-yl)-2-cyclopropyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;6-(cyclohexen-1-yl)-2-methyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;N-(cyclopentylmethyl)-8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazine-2-carboxamide;(4-methylpiperazin-1-yl)-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone;morpholin-4-yl-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone
SMILESC[C@@H](Nc1nc(C2CC2)nn2cc(C3=CCCCC3)cc12)c1cccc(C(F)(F)F)c1.C[C@@H](Nc1nccn2cc(C(=O)N3CCN(C)CC3)nc12)c1cccc(C(F)(F)F)c1.C[C@@H](Nc1nccn2cc(C(=O)N3CCOCC3)nc12)c1cccc(C(F)(F)F)c1.C[C@@H](Nc1nccn2cc(C(=O)NCC3CCCC3)nc12)c1cccc(C(F)(F)F)c1.Cc1nc(N[C@H](C)c2cccc(C(F)(F)F)c2)c2cc(C3=CCCCC3)cn2n1
InChIInChI=1S/C24H25F3N4.C22H24F3N5O.C22H23F3N4.C21H23F3N6O.C20H20F3N5O2/c1-15(18-8-5-9-20(12-18)24(25,26)27)28-23-21-13-19(16-6-3-2-4-7-16)14-31(21)30-22(29-23)17-10-11-17;1-14(16-7-4-8-17(11-16)22(23,24)25)28-19-20-29-18(13-30(20)10-9-26-19)21(31)27-12-15-5-2-3-6-15;1-14(17-9-6-10-19(11-17)22(23,24)25)26-21-20-12-18(16-7-4-3-5-8-16)13-29(20)28-15(2)27-21;1-14(15-4-3-5-16(12-15)21(22,23)24)26-18-19-27-17(13-30(19)7-6-25-18)20(31)29-10-8-28(2)9-11-29;1-13(14-3-2-4-15(11-14)20(21,22)23)25-17-18-26-16(12-28(18)6-5-24-17)19(29)27-7-9-30-10-8-27/h5-6,8-9,12-15,17H,2-4,7,10-11H2,1H3,(H,28,29,30);4,7-11,13-15H,2-3,5-6,12H2,1H3,(H,26,28)(H,27,31);6-7,9-14H,3-5,8H2,1-2H3,(H,26,27,28);3-7,12-14H,8-11H2,1-2H3,(H,25,26);2-6,11-13H,7-10H2,1H3,(H,24,25)/t15-;3*14-;13-/m11111/s1
InChIKeyAGGBCGHHCFWNTG-BKZBUSBYSA-N
XLogP24.49
TPSA293.29 Ų
H-Bond Donors6
H-Bond Acceptors25
Rotatable Bonds23
Heavy Atoms152
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002110.25
LogP ≤ 524.49
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1025

Analyze 6-(cyclohexen-1-yl)-2-cyclopropyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;6-(cyclohexen-1-yl)-2-methyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;N-(cyclopentylmethyl)-8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazine-2-carboxamide;(4-methylpiperazin-1-yl)-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone;morpholin-4-yl-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-(cyclohexen-1-yl)-2-cyclopropyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;6-(cyclohexen-1-yl)-2-methyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;N-(cyclopentylmethyl)-8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazine-2-carboxamide;(4-methylpiperazin-1-yl)-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone;morpholin-4-yl-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone?
The IUPAC name of 6-(cyclohexen-1-yl)-2-cyclopropyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;6-(cyclohexen-1-yl)-2-methyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;N-(cyclopentylmethyl)-8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazine-2-carboxamide;(4-methylpiperazin-1-yl)-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone;morpholin-4-yl-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone (CID 164948881) is 6-(cyclohexen-1-yl)-2-cyclopropyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;6-(cyclohexen-1-yl)-2-methyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;N-(cyclopentylmethyl)-8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazine-2-carboxamide;(4-methylpiperazin-1-yl)-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone;morpholin-4-yl-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone.
What is the SMILES notation for 6-(cyclohexen-1-yl)-2-cyclopropyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;6-(cyclohexen-1-yl)-2-methyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;N-(cyclopentylmethyl)-8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazine-2-carboxamide;(4-methylpiperazin-1-yl)-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone;morpholin-4-yl-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone?
The canonical SMILES for 6-(cyclohexen-1-yl)-2-cyclopropyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;6-(cyclohexen-1-yl)-2-methyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;N-(cyclopentylmethyl)-8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazine-2-carboxamide;(4-methylpiperazin-1-yl)-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone;morpholin-4-yl-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone is C[C@@H](Nc1nc(C2CC2)nn2cc(C3=CCCCC3)cc12)c1cccc(C(F)(F)F)c1.C[C@@H](Nc1nccn2cc(C(=O)N3CCN(C)CC3)nc12)c1cccc(C(F)(F)F)c1.C[C@@H](Nc1nccn2cc(C(=O)N3CCOCC3)nc12)c1cccc(C(F)(F)F)c1.C[C@@H](Nc1nccn2cc(C(=O)NCC3CCCC3)nc12)c1cccc(C(F)(F)F)c1.Cc1nc(N[C@H](C)c2cccc(C(F)(F)F)c2)c2cc(C3=CCCCC3)cn2n1.
What is the InChIKey of 6-(cyclohexen-1-yl)-2-cyclopropyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;6-(cyclohexen-1-yl)-2-methyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;N-(cyclopentylmethyl)-8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazine-2-carboxamide;(4-methylpiperazin-1-yl)-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone;morpholin-4-yl-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone?
The InChIKey is AGGBCGHHCFWNTG-BKZBUSBYSA-N. The full InChI is InChI=1S/C24H25F3N4.C22H24F3N5O.C22H23F3N4.C21H23F3N6O.C20H20F3N5O2/c1-15(18-8-5-9-20(12-18)24(25,26)27)28-23-21-13-19(16-6-3-2-4-7-16)14-31(21)30-22(29-23)17-10-11-17;1-14(16-7-4-8-17(11-16)22(23,24)25)28-19-20-29-18(13-30(20)10-9-26-19)21(31)27-12-15-5-2-3-6-15;1-14(17-9-6-10-19(11-17)22(23,24)25)26-21-20-12-18(16-7-4-3-5-8-16)13-29(20)28-15(2)27-21;1-14(15-4-3-5-16(12-15)21(22,23)24)26-18-19-27-17(13-30(19)7-6-25-18)20(31)29-10-8-28(2)9-11-29;1-13(14-3-2-4-15(11-14)20(21,22)23)25-17-18-26-16(12-28(18)6-5-24-17)19(29)27-7-9-30-10-8-27/h5-6,8-9,12-15,17H,2-4,7,10-11H2,1H3,(H,28,29,30);4,7-11,13-15H,2-3,5-6,12H2,1H3,(H,26,28)(H,27,31);6-7,9-14H,3-5,8H2,1-2H3,(H,26,27,28);3-7,12-14H,8-11H2,1-2H3,(H,25,26);2-6,11-13H,7-10H2,1H3,(H,24,25)/t15-;3*14-;13-/m11111/s1.
What are the key properties of 6-(cyclohexen-1-yl)-2-cyclopropyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;6-(cyclohexen-1-yl)-2-methyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;N-(cyclopentylmethyl)-8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazine-2-carboxamide;(4-methylpiperazin-1-yl)-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone;morpholin-4-yl-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone?
6-(cyclohexen-1-yl)-2-cyclopropyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;6-(cyclohexen-1-yl)-2-methyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;N-(cyclopentylmethyl)-8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazine-2-carboxamide;(4-methylpiperazin-1-yl)-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone;morpholin-4-yl-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone has a molecular weight of 2110.25 g/mol, XLogP of 24.49, 23 rotatable bonds, 6 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for 6-(cyclohexen-1-yl)-2-cyclopropyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;6-(cyclohexen-1-yl)-2-methyl-N-[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]pyrrolo[2,1-f][1,2,4]triazin-4-amine;N-(cyclopentylmethyl)-8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazine-2-carboxamide;(4-methylpiperazin-1-yl)-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone;morpholin-4-yl-[8-[[(1R)-1-[3-(trifluoromethyl)phenyl]ethyl]amino]imidazo[1,2-a]pyrazin-2-yl]methanone is sourced from PubChem (CID 164948881), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).